Revolution Medicines (RVMD)
NASDAQ:RVMD
Holding RVMD?
Track your performance easily

Revolution Medicines (RVMD) Financial Statements

272 Followers

Revolution Medicines Financial Overview

Revolution Medicines's market cap is currently ―. The company's EPS TTM is $-3.647; its P/E ratio is -12.98; Revolution Medicines is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 742.00K-$ 3.82M
Gross Profit--$ 742.00K-$ 3.82M
EBIT$ -133.23M$ -140.86M$ -132.39M$ -112.30M$ -98.30M
EBITDA$ -115.20M$ -138.10M$ -129.53M$ -115.26M$ -98.00M
Net Income Common Stockholders$ -135.14M$ -116.00M$ -161.54M$ -108.43M$ -98.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.59B$ 1.70B$ 1.85B$ 813.20M$ 909.49M
Total Assets$ 1.81B$ 1.91B$ 2.06B$ 984.23M$ 1.07B
Total Debt$ 87.41M$ 88.03M$ 87.94M$ 62.85M$ 63.26M
Net Debt$ -1.50B$ -1.62B$ -1.77B$ -750.35M$ -846.23M
Total Liabilities$ 189.59M$ 182.90M$ 235.51M$ 146.77M$ 142.87M
Stockholders Equity$ 1.61B$ 1.68B$ 1.83B$ 837.46M$ 930.87M
Cash Flow-
Free Cash Flow$ -130.57M$ -163.73M$ -122.88M$ -103.03M$ 300.00K
Operating Cash Flow$ -128.17M$ -160.56M$ -120.56M$ -100.50M$ 300.00K
Investing Cash Flow$ 107.94M$ -247.97M$ -380.40M$ 77.35M-
Financing Cash Flow$ 7.50M$ 810.00K$ 839.35M$ 1.01M-
Currency in USD

Revolution Medicines Earnings and Revenue History

Revolution Medicines Debt to Assets

Revolution Medicines Cash Flow

Revolution Medicines Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis